Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice


Por: Chivite, I, Monelli, E, Munar-Gelabert, M, Gómez-Valadés, AG, Alvarado-Diaz, A, Pozo, M, Varela, L, Ramírez, S, Haddad-Tóvolli, R, Toledo, M, Fos-Domènech, J, Díaz-Castro, F, Tahiri, I, García-Ramón, P, Ferreira, M, Van Gelder, C, Abot, A, Osorio-Conles, O, Valer, JA, Obri, A, Milà-Guasch, M, Luis, JA, Villacampa, P, Eyre, E, Altirriba, J, Genssler, S, Haake, M, Schuberth-Wagner, C, Remesar, X, Zorzano, A, Garcia-Rové, PM, Ventura, F, Vidal, J, Knauf, C, Nogueiras, RN, Horvath, TL, De Bock, K, Graupera, M and Claret, M

Publicada: 3 mar 2026 Ahead of Print: 1 mar 2026
Resumen:
Endothelial cells (ECs) are key metabolic gatekeepers, yet their role in metabolic health remains unclear. Given their central involvement in energy metabolism, mitochondria are ideally positioned to enable ECs to adapt to ever-changing metabolic requirements. Here, we explore the hypothesis that mitochondrial dynamics proteins in ECs influence whole-body metabolic status. Genetic deficiency of Mfn2 in ECs (Mfn2i Delta EC), but not of Mfn1i Delta EC, induces a mitohormetic response in the adipose vasculature, enhancing antioxidant defenses, mitochondrial fitness, and lipid oxidation, ultimately improving metabolic outcomes. Cultured ECs secrete the mitokine growth differentiation factor 15 (GDF15) via a forkhead box O1 (FOXO1)-dependent axis, a response also observed under stress conditions in vivo. Notably, Mfn2 i Delta EC mice exhibited elevated endothelial and circulating GDF15 levels, and neutralization of GDF15 partly attenuated their metabolic benefits. Consistent with mitohormetic activation, Mfn2i Delta EC mice showed protection against diet-induced obesity and delayed age-related decline. Hence, vascular mitohormetic adaptations emerge as a novel mechanism promoting systemic metabolic health.

Filiaciones:
Chivite, I:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Monelli, E:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

:
 Josep Carreras Leukaemia Res Inst IJC, Endothelial Pathobiol & Microenvironm Grp, Badalona 08916, Catalonia, Spain

Gómez-Valadés, AG:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Alvarado-Diaz, A:
 Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Exercise & Hlth, Swiss Fed Inst Technol, CH-8603 Zurich, Switzerland

Pozo, M:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Varela, L:
 Univ A Coruna, CICA Ctr Interdisciplinar Quim & Biol, La Coruna 15071, Spain

 Univ A Coruna, Dept Fisioterapia Med & Ciencias Biomed, MEtCaEn Grp, Fac Ciencias Saude, La Coruna 15006, Spain

 Hosp Univ A Coruna, Inst Invest Biomed INIBIC, La Coruna 15006, Spain

Ramírez, S:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Haddad-Tóvolli, R:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Toledo, M:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Fos-Domènech, J:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Díaz-Castro, F:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Tahiri, I:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

García-Ramón, P:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Ferreira, M:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Van Gelder, C:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Abot, A:
 Univ Paul Sabatier, INSERM, Inst Rech Sante Digest & Nutr IRSD, U1220, Toulouse, France

 INSERM, Int Res Project IRP, NeuroMicrobiota, Toulouse, France

Osorio-Conles, O:
 Hosp Clin Barcelona, Endocrinol & Diabet Dept, Obes Unit, Barcelona 08036, Catalonia, Spain

 CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain

Valer, JA:
 Univ Barcelona, Bellvitge Biomed Res Inst IDIBELL, Dept Ciencies Fisiolog, Lhospitalet De Llobregat, Catalonia, Spain

Obri, A:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Milà-Guasch, M:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Luis, JA:
 Univ Barcelona, Bellvitge Biomed Res Inst IDIBELL, Dept Ciencies Fisiolog, Lhospitalet De Llobregat, Catalonia, Spain

Villacampa, P:
 Univ Barcelona, Bellvitge Biomed Res Inst IDIBELL, Dept Ciencies Fisiolog, Lhospitalet De Llobregat, Catalonia, Spain

Eyre, E:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

Altirriba, J:
 Univ Geneva, Fac Med, Lab Metab, Geneva, Switzerland

Genssler, S:
 CatalYm GmbH, Klopferspitz 19, D-82152 Martinsried, Germany

Haake, M:
 CatalYm GmbH, Klopferspitz 19, D-82152 Martinsried, Germany

Schuberth-Wagner, C:
 CatalYm GmbH, Klopferspitz 19, D-82152 Martinsried, Germany

Remesar, X:
 Univ Barcelona, Dept Bioquim Biomed Mol, Fac Biol, Barcelona 08028, Catalonia, Spain

 Univ Barcelona, Inst Biomed, Barcelona 08028, Catalonia, Spain

 CIBER Fisiopatol Obes & Nutr CIBEROBN, Madrid, Spain

Zorzano, A:
 CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain

 Univ Barcelona, Dept Bioquim Biomed Mol, Fac Biol, Barcelona 08028, Catalonia, Spain

 Inst Res Biomed IRB Barcelona, Barcelona 08028, Catalonia, Spain

Garcia-Rové, PM:
 Univ Barcelona, Bellvitge Biomed Res Inst IDIBELL, Dept Ciencies Fisiolog, Lhospitalet De Llobregat, Catalonia, Spain

 CIBER Fisiopatol Obes & Nutr CIBEROBN, Madrid, Spain

Ventura, F:
 Univ Barcelona, Bellvitge Biomed Res Inst IDIBELL, Dept Ciencies Fisiolog, Lhospitalet De Llobregat, Catalonia, Spain

Vidal, J:
 Hosp Clin Barcelona, Endocrinol & Diabet Dept, Obes Unit, Barcelona 08036, Catalonia, Spain

 CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain

Nogueiras, RN:
 CIBER Fisiopatol Obes & Nutr CIBEROBN, Madrid, Spain

 Univ Santiago de Compostela, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Dept Physiol, Inst Invest Sanitaria IDIS, Santiago de Compostela 15782, Spain

Horvath, TL:
 Yale Univ, Ctr Mol & Syst Metab, Dept Comparat Med, Sch Med, New Haven, CT 06520 USA

 Univ Vet Med, Dept Anat & Histol, Budapest, Hungary

De Bock, K:
 Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Exercise & Hlth, Swiss Fed Inst Technol, CH-8603 Zurich, Switzerland

:
 Josep Carreras Leukaemia Res Inst IJC, Endothelial Pathobiol & Microenvironm Grp, Badalona 08916, Catalonia, Spain

 CIBER Canc CIBERONC, Madrid, Spain

 Inst Catalana Recerca & Estudis Avancats, ICREA, Barcelona 08010, Catalonia, Spain

Claret, M:
 Inst Invest Biomed August Pi i Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona 08036, Catalonia, Spain

 CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain

 Univ Barcelona, Sch Med, Barcelona 08036, Catalonia, Spain
ISSN: 15504131





Cell Metabolism
Editorial
Cell Press, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 38 Número: 3
Páginas:
WOS Id: 001710221900001
ID de PubMed: 41709465
imagen Green Submitted, hybrid

MÉTRICAS